# Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

> **NCT03451916** · PHASE3 · COMPLETED · sponsor: **Pluristem Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Hip Fracture

## Interventions

- **DRUG:** PLX-PAD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03451916
- **Lead sponsor:** Pluristem Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2022-04-29
- **Final completion:** 2023-09-06
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451916, "Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03451916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*